Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins

DOI Web Site 被引用文献1件
  • T.D. Graves
    From the MRC Centre for Neuromuscular Diseases (T.D.G., S.R., S.S., M.G.H., D.M.K.), UCL Institute of Neurology, Queen Square, London; Fraser of Allander Neurosciences Unit (S.M.Z.), Royal Hospital for Sick Children, Yorkhill, Glasgow; and MRC Centre for Neuropsychiatric Genetics and Genomics (H.R.M.), Cardiff University School of Medicine, UK.
  • S. Rajakulendran
    From the MRC Centre for Neuromuscular Diseases (T.D.G., S.R., S.S., M.G.H., D.M.K.), UCL Institute of Neurology, Queen Square, London; Fraser of Allander Neurosciences Unit (S.M.Z.), Royal Hospital for Sick Children, Yorkhill, Glasgow; and MRC Centre for Neuropsychiatric Genetics and Genomics (H.R.M.), Cardiff University School of Medicine, UK.
  • S.M. Zuberi
    From the MRC Centre for Neuromuscular Diseases (T.D.G., S.R., S.S., M.G.H., D.M.K.), UCL Institute of Neurology, Queen Square, London; Fraser of Allander Neurosciences Unit (S.M.Z.), Royal Hospital for Sick Children, Yorkhill, Glasgow; and MRC Centre for Neuropsychiatric Genetics and Genomics (H.R.M.), Cardiff University School of Medicine, UK.
  • H.R. Morris
    From the MRC Centre for Neuromuscular Diseases (T.D.G., S.R., S.S., M.G.H., D.M.K.), UCL Institute of Neurology, Queen Square, London; Fraser of Allander Neurosciences Unit (S.M.Z.), Royal Hospital for Sick Children, Yorkhill, Glasgow; and MRC Centre for Neuropsychiatric Genetics and Genomics (H.R.M.), Cardiff University School of Medicine, UK.
  • S. Schorge
    From the MRC Centre for Neuromuscular Diseases (T.D.G., S.R., S.S., M.G.H., D.M.K.), UCL Institute of Neurology, Queen Square, London; Fraser of Allander Neurosciences Unit (S.M.Z.), Royal Hospital for Sick Children, Yorkhill, Glasgow; and MRC Centre for Neuropsychiatric Genetics and Genomics (H.R.M.), Cardiff University School of Medicine, UK.
  • M.G. Hanna
    From the MRC Centre for Neuromuscular Diseases (T.D.G., S.R., S.S., M.G.H., D.M.K.), UCL Institute of Neurology, Queen Square, London; Fraser of Allander Neurosciences Unit (S.M.Z.), Royal Hospital for Sick Children, Yorkhill, Glasgow; and MRC Centre for Neuropsychiatric Genetics and Genomics (H.R.M.), Cardiff University School of Medicine, UK.
  • D.M. Kullmann
    From the MRC Centre for Neuromuscular Diseases (T.D.G., S.R., S.S., M.G.H., D.M.K.), UCL Institute of Neurology, Queen Square, London; Fraser of Allander Neurosciences Unit (S.M.Z.), Royal Hospital for Sick Children, Yorkhill, Glasgow; and MRC Centre for Neuropsychiatric Genetics and Genomics (H.R.M.), Cardiff University School of Medicine, UK.

収録刊行物

  • Neurology

    Neurology 75 (4), 367-372, 2010-07-27

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (1)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ